Background illustration for clinical trials search

Paid Clinical Trials Pittsburgh

Discover 1,166 paid clinical trials in Pittsburgh, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

for
Castration-Resistant Prostatic Cancer, Metastasis
Location: Pittsburgh PA, Washington D.C. DC, Toronto,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06863272

Phase 1, Phase 2, Recruiting

Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma

for
Locally Advanced Melanoma
Location: Pittsburgh PA
Sponsor: John Kirkwood

Sex: All

Age: 18+

Code: NCT07223411

Recruiting

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Pittsburgh PA, Morgantown WV, Fairfax VA, Richmond VA,
Sponsor: TuHURA Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06947928

Phase 2, Phase 3, Recruiting

Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia

for
Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia,
Location: Pittsburgh PA, Columbus OH, Bethesda MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06965114

Phase 1, Phase 2, Recruiting

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Location: Pittsburgh PA, Cleveland OH, Philadelphia PA,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07140900

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

for
Non-Muscle Invasive Bladder Neoplasms
Location: Pittsburgh PA, Gahanna OH, Lancaster PA, Royal Oak MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06919965

Phase 3, Recruiting

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostatic Neoplasms
Location: Pittsburgh PA, Cleveland OH, Fairfax VA,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07164443

Phase 3, Recruiting

Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES

for
CARES, Standard of Care
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT07183527

Recruiting

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Pittsburgh PA, Morgantown WV, Fairfax VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06997497

Phase 3, Recruiting

A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

for
Non Small Cell Lung Cancer
Location: Pittsburgh PA, Cleveland OH, Fairfax VA, Detroit MI,
Sponsor: Wayshine Biopharm, Inc.

Sex: All

Age: 18+

Code: NCT06868485

Phase 2, Recruiting

ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC

for
Triple Negative Breast Cancer
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: Female

Age: 18+

Code: NCT07332975

Recruiting

Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers

for
Stem Cell Transplant, Hematopoetic Stem Cell Transplant,
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT07107165

Recruiting

Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)

for
Esophageal Cancer, Esophageal Carcinoma
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT06872515

Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Pittsburgh PA, Hershey PA, Baltimore MD, Toronto,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase 3, Recruiting

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Pittsburgh PA, Monroeville PA, Greensburg PA,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06532279

Phase 2, Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Pittsburgh PA, Cleveland OH, Columbus OH, Buffalo NY,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06943755

Phase 2, Phase 3, Recruiting

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

for
Renal Cell Carcinoma
Location: Pittsburgh PA, Durham NC, New York NY, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07049926

Phase 1, Phase 2, Recruiting

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: Pittsburgh PA, Morgantown WV, Cleveland OH, Fairfax VA,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07029399

Phase 1, Recruiting

A Phase 1 Study of the Safety and Tolerability of CTX-10726

for
Gastroesophageal Cancer (GC), Hepatocellular Carcinoma (HCC),
Location: Pittsburgh PA, Lake Success NY, Greenville SC,
Sponsor: Compass Therapeutics

Sex: All

Age: 18+

Code: NCT07419841

Phase 1, Recruiting

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Pittsburgh PA, Columbus OH, Washington D.C. DC,
Sponsor: AVEO Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06064877

Phase 3, Recruiting